The effective clinical study of Edaravone on treatment of cerebral infarction and the changes of IL-6 and IL-13 in serum
FU Xue-ju
Abstract
FU Xue-ju
Abstract
Objective To detect their expressions of IL-6 and IL-13,and the relationship with Edaravone in cerebral infarction,and investigate their clinical significance.Methods 81 cases with cerebral infarction were divided into two groups.The observation group(50 cases)was treated by routine and Edaravone treatment.The control group(31 cases)was treated by routine treatment.The expressions of IL-6 and IL-13 were detected in pre-treatment and post-treatment of Edaravone.We observed their efficacy of Edaravone.Results The expressions of IL-6 and IL-13 were obviously significant in pre-treatment and post-treatment by Edaravone.But the decrease of IL-6 and IL-13 were higher in the observation group than in the control group.The total effective rate was obviously higher in the observation group than in the control group.Conclusion The Edaravone can inhibit the expressions of IL-6 and IL-13,and protect the cerebral cells in cerebral infarction.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To detect their expressions of IL-6 and IL-13,and the relationship with Edaravone in cerebral infarction,and investigate their clinical significance.Methods 81 cases with cerebral infarction were divided into two groups.The observation group(50 cases)was treated by routine and Edaravone treatment.The control group(31 cases)was treated by routine treatment.The expressions of IL-6 and IL-13 were detected in pre-treatment and post-treatment of Edaravone.We observed their efficacy of Edaravone.Results The expressions of IL-6 and IL-13 were obviously significant in pre-treatment and post-treatment by Edaravone.But the decrease of IL-6 and IL-13 were higher in the observation group than in the control group.The total effective rate was obviously higher in the observation group than in the control group.Conclusion The Edaravone can inhibit the expressions of IL-6 and IL-13,and protect the cerebral cells in cerebral infarction.
Key concepts: Edaravone, Medicine, Cerebral infarction, Clinical efficacy, Anesthesia, Clinical treatment, Pharmacology, Internal medicine